The World Health Organization has classified the EG.5 family of Omicron variants, including Eris, as ‘variants of interest’. What does that mean? And how does Eris differ to other Omicron variants?
L’expertise universitaire, l’exigence journalistique
Articles sur Omicron sub-variants
Ensemble des articles
Australia is in the middle of its fifth Omicron wave, which has been brewing since February. But it’s been slow and drawn out and the health impacts are very different to earlier waves.
Many questions remain about next steps for US vaccine policy. But the FDA advisory panel’s hearty endorsement of a single-composition COVID-19 vaccine represents a pivotal step.
The new bivalent boosters against COVID-19 have failed to halt omicron infections. However, new technologies are being developed that pave a way forward.
The evidence so far suggests this wave could be a shorter and smaller version of the Omicron BA.5 wave.
There are so many forms of the virus, it’s hard to keep up. Here’s what to expect next as the virus mutates and recombines.
Just because a variant spreads faster, it doesn’t necessarily mean it has a higher R0.
What’s the difference between a variant and a subvariant? It’s all in the behaviour.
Les contributeurs les plus fréquents
-
Professor, epidemiological modelling of infectious diseases, UNSW Sydney
-
Professor in Mathematical Biology, The University of Melbourne
-
Research Fellow, Epidemic Decision Support, The University of Melbourne
-
Instructor of Human Immunology, Emory University
-
Chair in Epidemiology, Deakin University
-
Honorary Research Fellow, Telethon Kids Institute, and Professor, Curtin School of Population Health, Curtin University
-
Professor, Infectious Diseases and Microbiology, The University of Queensland
-
Associate Professor, Immunovirology and Pathogenesis Program, Kirby Institute, UNSW Sydney
-
Associate Professor, Epidemiology, Deakin University
-
Research fellow, CSIRO
-
Australian Research Council Future Fellow, The University of Melbourne
